80021419: International College of Geriatric Psychoneuropharmacology

Click here for a text version of the brochure
Text version of brochure

ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The Johns Hopkins University School of Medicine and the International College of Geriatric Psychoneuropharmacology. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 21.75 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
OTHER CREDIT
This CME activity is endorsed by the American Geriatrics Society. Credits earned from this activity may be counted toward the AGS Geriatrics Recognition Award. The Johns Hopkins University has approved this activity for 21.75 contact hours for non-physicians. The Johns Hopkins University School of Medicine is authorized by the State Board of Examiners of Psychologists as a provider of continuing education. The Johns Hopkins University School of Medicine maintains responsibility for this program. A certificate for 21.75 CEUs will be awarded upon completion of this activity. The Maryland Board of Social Work Examiners certifies that this program meets the criteria for 21.75 credit hours of Category 1 or 21.75 CEUs of continuing education for social workers and associates licensed in Maryland.
This CE Program has been approved by the Maryland Board of Professional Counselors and Therapists for Category A.

For additional conference information, please visit the ICGP Website: www.icgp.org

The theme of the meeting will be "New Frontiers in Geriatric Psychoneuropharmacology", with a focus on novel therapeutic interventions, molecular targets, and methodology. As always, we hope to encourage both basic and clinical investigators, as well as junior and senior colleagues to submit panels.

Abstracts for Poster Presentation:
We are now inviting abstracts for poster presentation for the meeting. The guidelines for submission of poster abstracts are as below. The submissions can be made by the on-line abstract submission form. Alternatively, they can be submitted by email as a MSWord file to lagattutase@upmc.edu

Deadlines:
Submission of abstracts for posters: October 9, 2009

Guidelines for Abstracts:
1. An Abstract comprises the following:
    a. Names of authors, with the name of the presenter underlined.
    b. Affiliations
    c. Content of the abstract, structured under the following headings:
        i. Background
        ii. Methods
        iii. Results
        iv. Conclusions.
2. Do not exceed the word limit of 250 words.
3. Make a brief statement of any potential conflict of interest.

Link to Abstract Submission Form http://icgp.org/main/AbstractForm

The scientific committee will make the final decision about the acceptance of the Abstract for the meeting.

Gwenn Smith and Paul Francis
Co-Chairs, Program Committee

Description:
The ICGP was founded in 2000 with the mission to further clinical care, research and education in geriatric psychoneuropharmacology by fostering cross-fertilization of scientific knowledge among clinical and preclinical scientists from different related disciplines. The number of elderly people with neuropsychiatric disorders is increasing rapidly all over the world — in developing as well as developed countries. In the U.S., the number of psychiatrically ill older persons is estimated to quadruple by the year 2030. More effective treatment strategies will be needed to lessen the disability and public health burden generated by neuropsychiatric disorders. Advances in such fields as psychopharmacology, therapeutics, genetics and neuro-imaging are occurring at an unprecedented rate. There is an increasing need to translate the knowledge from basic and clinical research into more effective prevention and intervention and strategies. The theme of the ninth annual meeting will be “New Frontiers in Geriatric Psychoneuropharmacology”, with a focus on novel therapeutic interventions, molecular targets and cutting edge methodologies. The program will include scientific sessions as well as plenary lectures from the leading international preclinical and clinical scientists.

Objectives
After attending this activity, the participant will demonstrate the ability to:
• Discuss and integrate scientific information from basic and clinical research relevant to geriatric psychoneuropharmacology
• Describe basic and clinical research methodologies necessary for treatment development and for clinical evaluation with the goal of developing more effective prevention and intervention approaches to prevent and treat neuropsychiatric disorders in aging individuals
• Apply the information obtained to improve the health and well-being of the aging individuals with neuropsychiatric disorders who are residing in many culturally distinct societies world-wide

Talks

Policy On Speaker And Provider Disclosure

It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity handout materials.